ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628562 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628562; 2) Community: the network communities that were significantly associated with the response to NSC 628562; 3) Molecule: the relationships between components within communities and NSC 628562; 4) MDR: the compounds that were significantly associated with the NSC 628562.

NSC Compound Enrichment Correlation
NSC 218476 .beta.-D-Glucopyranose, 6-thio-, 6-(dimethylarsinite) 0.000294004970380715 0.5902415
NSC 667049 2-ethenyl estradiol 0.000294004970380715 0.33629404
NSC 708049 Piperazine-2,2,5,5-tetracarbonitrile, 3,6-dipropyl- 0.000294004970380715 0.51696525
NSC 348402 Null 0.000316069426108867 0.38907853
NSC 644908 Null 0.000345299270690659 0.70919753
NSC 655105 Cycloshikonin 0.000345299270690659 0.61511819
NSC 657321 1,9-Dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone, 8,16-bis(2-oxopropyl)-, [8S-(3E,8R*,11E,16R*)]- 0.000345299270690659 0.63031232
NSC 674919 Furan-3(2H)-one, 2-[2-(4-bromophenyl)-2-oxoethylidene]- 5-(2,4-dimethylphenyl)- 0.000345299270690659 0.64511384
NSC 628591 Null 0.000497857311992523 0.41388572
NSC 639516 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride 0.000497857311992523 0.48296711
Total:111  Current:5    [First] [Prev] [Next] [Last]